02/24/2024 00:26:53
  • Home | EDS: Treating a medical zebra
  • Scandinavian Health Ltd
  • Editorial
  • Emirates SkyCargo
  • Contents
  • Nolato Company Insight
  • Nolato
  • News
  • The pharma industry briefing
  • Subcuject Company Insight
  • Subcuject
  • Horizon 2020: a look back at flagship EU pharma projects
  • Sanofi
  • Sky high: should US drug prices fall in-line with the rest of the world?
  • Nipro Pharmapackaging
  • Q&A: talking drug quality with Valisure, the first analytical pharmacy
  • Nemera
  • What does ‘ageing’ mean when it comes to drug development?
  • Swiss WorldCargo
  • Manufacturing medicines in space: how astronauts will make their own drugs
  • Mimotopes
  • Aducanumab’s surprising revival: how an Alzheimer’s drug came back from the dead
  • Molnar Company Insight
  • Molnar-Institute
  • Ehlers-Danlos syndrome: The zebra in the room
  • Kugelmeiers
  • Stop ignoring the two billion: pharma’s role in expanding access to medicine
  • Skyepharma
  • IDMP: turning attention to patient benefits
  • Deals in brief powered by GlobalData
  • The key list powered by GlobalData
  • Events
  • Next issue
01/24/2020 00:00:00